753
Views
14
CrossRef citations to date
0
Altmetric
Review Articles

Adrenal disorders in pregnancy, labour and postpartum – an overview

, &

References

  • Abbassy M, Kshettry VR, Hamrahian AH, Johnston PC, Dobri GA, Avitsian R. 2015. Surgical management of recurrent Cushing's disease in pregnancy: a case report. Surgical Neurology International 6:S640–S645.
  • Abdelmannan D, Aron DC. 2011. Adrenal disorders in pregnancy. Endocrinology and Metabolism Clinics of North America 40:779–794.
  • Abd-Elsayed AA, Díaz-Gómez J, Barnett GH, Kurz A, Inton-Santos M, Barsoum S, et al. 2013. A case series discussing the anaesthetic management of pregnant patients with brain tumours. F1000Res 2:92.
  • Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, et al. 2006. Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. The Journal of Clinical Endocrinology & Metabolism 91:2650–2655.
  • Abiven-Lepage G, Coste J, Tissier F, Groussin L, Billaud L, Dousset B, et al. 2010. Adrenocortical carcinoma and pregnancy: clinical and biological features and prognosis. European Journal of Endocrinology 163:793–800.
  • Allolio B, Fassnacht M. 2006. Clinical review: adrenocortical carcinoma: clinical update. The Journal of Clinical Endocrinology and Metabolism 91:2027–2037.
  • Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, et al. 2005. Genetic testing in pheochromocytoma or functional paraganglioma. Journal of Clinical Oncology 23:8812–8818.
  • Ambroziak U, Kondracka A, Bartoszewicz Z, Krasnodębska-Kiljańska M, Bednarczuk T. 2015. The morning and late-night salivary cortisol ranges for healthy women may be used in pregnancy. Clinical Endocrinology 83:774–778.
  • Anand G, Beuschlein F. 2018. Fertility, pregnancy and lactation in women with adrenal insufficiency. European Journal of Endocrinology 178:R45–R53.
  • Aplin SC, Yee KF, Cole MJ. 2004. Neonatal effects of long-term maternal phenoxybenzamine therapy. Anesthesiology 100:1608–1610.
  • Aporowicz M, Domosławski P, Czopnik P, Sutkowski K, Kaliszewski K. 2018. Perioperative complications of adrenalectomy- 12 years of experience from a single centre/teaching hospital and literature review. Archives of Medical Science 14:1010–1019.
  • Arlt W, Allolio B. 2003. Adrenal insufficiency. Lancet (London, England) 361:1881–1893.
  • Assoufi N, Bahadi N, Omri NE, Sekkach Y, Ameziane T, Ghafir D. 2016. Tetraparesis revealing Conn adenoma in a pregnant woman. The Pan African Medical Journal 25:24.
  • Berwaerts J, Verhelst J, Mahler C, Abs R. 1999. Cushing’s syndrome in pregnancy treated by ketoconazole: case report and review of the literature. Gynecological Endocrinology 13:175–182.
  • Biggar MA, Lennard TW. 2013. Systematic review of phaeochromocytoma in pregnancy. The British Journal of Surgery 100:182–190.
  • Blanco C, Maqueda E, Rubio JA, Rodriguez A. 2006. Cushing’s syndrome during pregnancy secondary to adrenal adenoma: metyrapone treatment and laparoscopic adrenalectomy. Journal of Endocrinological Investigation 29:164–167.
  • Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. 2016. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism 101:364–389.
  • Boronat M, Marrero D, López-Plasencia Y, Barber M, Schamann Y, Nóvoa FJ. 2011. Successful outcome of pregnancy in a patient with Cushing’s disease under treatment with ketoconazole during the first trimester of gestation. Gynecological Endocrinology 27:675–677.
  • Bravo EL, Tagle R. 2003. Pheochromocytoma: state of the art and future prospects. Endocrine Reviews 24:539–553.
  • Bronstein MD, Machado MC, Fragoso MC. 2015. Management of endocrine disease: management of pregnant patients with Cushing’s syndrome. European Journal of Endocrinology 173:R85–R91.
  • Brue T, Amodru V, Castinetti F. 2018. Management of Cushing’s syndrome during pregnancy: solved and unsolved questions. European Journal of Endocrinology 178:R259–R266.
  • Buffet A, Venisse A, Nau V, Roncellin I, Boccio V, Le Pottier N, et al. 2012. A decade (2001– 2010) of genetic testing for pheochromocytoma and paraganglioma. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones et Metabolisme 44:359–366.
  • Butters L, Kennedy S, Rubin PC. 1990. Atenolol in essential hypertension during pregnancy. BMJ (Clinical Research ed.) 301:587–589.
  • Caimari F, Valassi E, Garbayo P, Steffensen C, Santos A, Corcoy R, et al. 2017. Cushing's syndrome and pregnancy outcomes: a systematic review of published cases. Endocrine 55:555–563.
  • Carr BR, Parker CR, Madden JD, MacDonald PC, Porter JC. 1981. Maternal plasma adrenocorticotropsin and cortisol relationship throughout human pregnancy. American Journal of Obstetrics and Gynecology 139:416.
  • Choi WJ, Jung TS, Paik WY. 2011. Cushing’s syndrome in pregnancy with a severe maternal complication: a case report. Journal of Obstetrics and Gynaecology Research 37:163–167.
  • Crucitti F, Bellantone R, Ferrante A, Boscherini M, Crucitti P. 1996. The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multi-institutional series of 129 patients. The ACC Italian Registry Study Group. Surgery 119:161.
  • Dackiw AP, Lee JE, Gagel RF, Evans DB. 2001. Adrenal cortical carcinoma. World Journal of Surgery 25:914–926.
  • Day J, Batjer HH. 1995. Operative positioning and fetal monitoring considerations. In: Loftus M, editor. Neurosurgical aspects of pregnancy. Illinois: American Association of Neurological Surgeons. p. 183–190.
  • Derkx FHM, Alberda AT, De Jong FH, Zeilmaker FH, Makovitz JW, Schalekamp MADH. 1987. Source of plasma prorenin in early and late pregnancy: observations in a patient with primary ovarian failure. The Journal of Clinical Endocrinology & Metabolism 65:349–354.
  • Dluhy RG, Lifton RP. 1994. Glucocorticoid-remediable aldosteronism. Endocrinology and Metabolism Clinics of North America 23:285–297. [Medline].
  • Eguchi K, Hoshide S, Nagashima S, Maekawa T, Sasano H, Kario K. 2014. An adverse pregnancy-associated outcome due to overlooked primary aldosteronism. Internal Medicine 53:2499–2504.
  • Escher G. 2009. Hyperaldosteronism in pregnancy. Therapeutic Advances in Cardiovascular Disease 3:123–132.
  • Gicquel C, Bertherat J, Le Bouc Y, Bertagna X. 2000. Pathogenesis of adrenocortical incidentalomas and genetic syndromes associated with adrenocortical neoplasm. Endocrinology and Metabolism Clinics of North America 29:1–13.
  • Grinspoon SK, Biller BM. 1994. Clinical review 62: laboratory assessment of adrenal insufficiency. The Journal of Clinical Endocrinology & Metabolism 79:923–931.
  • Groves TD, Corenblum B. 1995. Spironolactone therapy during human pregnancy. American Journal of Obstetrics and Gynecology 172:1655–1656.
  • Grumbach MM, Biller BMK, Braunstein GD, Campbell KK, Carney JA, Godley PA, et al. 2003. Management of the clinically unapparent adrenal mass (“incidentaloma”). Annals of Internal Medicine 138:424–429.
  • Gunganah K, Carpenter R, Drake WH. 2016. Eplerenone use in primary aldosteronism during pregnancy. Clinical Case Reports 4:81–82.
  • Harrington JL, Farley DR, van Heerden JA, Ramin KD. 1999. Adrenal tumors and pregnancy. World Journal of Surgery 23:182–186.
  • Irani RA, Xia Y. 2008. The functional role of the renin–angiotensin system in pregnancy and preeclampsia. Placenta 29:763–771.
  • Kaloostian PE, Zadnik PL, Awad AJ, McCarthy E, Wolinsky J-P, Sciubba DM. 2013. En bloc resection of a pheochromocytoma metastatic to the spine for local tumor control and for treatment of chronic catecholamine release and related hypertension. Journal of Neurosurgery Spine 18:611–616.
  • Kaloostian PE, Zadnik PL, Kim JE, Groves ML, Wolinsky J-P, Gokaslan ZL, et al. 2014. High incidence of morbidity following resection of metastatic pheochromocytoma in the spine. Journal of Neurosurgery Spine 20:726–733.
  • Kapoor G, Salhan S, Sarda N, Sarda AK, Aggarwal D. 2013. Phaeochromocytoma in pregnancy: safe vaginal delivery, is it possible? Journal of the Indian Medical Association 111:266–267.
  • Katulski K, Podfigurna-Stopa A, Maciejewska-Jeske M, Ruchala M, Gurgul E, Szymankiewicz M, et al. 2014. Cushing's syndrome in pregnancy: a case report and mini review of the literature. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology 30:345–349.
  • Kimura Y, Okuyama K, Mitsui K, Tamaki F, Nonaka A, Matsukawa T. 2012. Anaesthetic management for laparoscopic adrenalectomy in a pregnant patient with Cushing's syndrome. Masui 61:605–609.
  • Kopf D, Goretzki PE, Lehnert H. 2001. Clinical management of malignant adrenal tumors. Journal of Cancer Research and Clinical Oncology 127:143–155.
  • Lacroix A. 2010. Approach to the patient with adrenocortical carcinoma. The Journal of Clinical Endocrinology and Metabolism 95:4812–4822.
  • Lekarev O, New MI. 2011. Adrenal disease in pregnancy. Best Practice & Research. Clinical Endocrinology & Metabolism 25:959–973.
  • Lenders JW. 2012. Pheochromocytoma and pregnancy: a deceptive connection. European Journal of Endocrinology 166:143–150.
  • Lenders JWM, Duh Q-Y, Eisenhofer G, Gimenez-Roqueplo A-P, Grebe SKG, Murad MH, et al. 2014. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism 99:1915–1942.
  • Lim WH, Torpy DJ, Jeffries WS. 2013. The medical management of Cushing's syndrome during pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 168:1–6.
  • Lindsay JR, Jonklaas J, Oldfield EH, Nieman LK. 2005. Cushing’s syndrome during pregnancy: personal experience and review of the literature. The Journal of Clinical Endocrinology & Metabolism 90:3077–3083.
  • Lopes LML, Francisco RPV, Galletta MAK, Bronstein MD. 2016. Determination of nighttime salivary cortisol during pregnancy: comparison with values in non-pregnancy and Cushing’s disease. Pituitary 19:30–38. https://doi.org/10.1007/s11102-015-0680-3
  • Luton JP, Cerdas S, Billaud L, Thomas G, Guilhaume B, Bertagna X, et al. 1990. Clinical features of adrenocortical carcinoma, prog- nostic factors, and the effect of mitotane therapy. New England Journal of Medicine 322:1195–1201.
  • Magiakou MA, Mastorakos G, Rabin D, Dubbert B, Gold PW, Chrousos GP. 1996. Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications of the increase in psychiatric manifestations at this time. Journal of Clinical Endocrinology & Metabolism 81:1912–1917.
  • McClamrock HD, Adashi EY. 1992. Gestational hyperandrogenism. Fertility and Sterility 57:257–274.
  • Morton A. 2015. Primary aldosteronism and pregnancy. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 5:259–262.
  • Nakhleh A, Saiegh L, Reut M, Ahmad MS, Pearl IW, Shechner C. 2016. Cabergoline treatment for recurrent Cushing's disease during pregnancy. Hormones 15:453–458.
  • Nassi R, Ladu C, Vezzosi C, Mannelli M. 2015. Cushing's syndrome in pregnancy. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology 31:102–104.
  • Ng L, Libertino JM. 2003. Adrenocortical carcinoma: diagnosis, evaluation and treatment. The Journal of Urology 169:5.
  • Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. 2008. The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism 93:1526–1540. https://doi.org/10.1210/jc.2008-0125.
  • Nolten WE, Lindheimer MD, Rueckert PA, Oparil S, Ehrlich EN. 1980. Diurnal patterns and regulation of cortison secretion in pregnancy. The Journal of Clinical Endocrinology and Metabolism 51:466.
  • Okamoto E, Takagi T, Makino T, Sata H, Iwata I, Nishino E, et al. 1989. Immunoreactive corticotropin-releasing hormone, adrenocorticotropin and cortisol in human plasma during pregnancy and delivery and postpartum. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones et Metabolisme 21:566–572.
  • Pickard J, Jochen AL, Sadur CN, Hofeldt FD. 1990. Cushings syndrome in pregnancy. Obstetrical & Gynecological Survey 45:87–93.
  • Prete A, Paragliola RM, Salvatori R, Corsello SM. 2016. Management of catecholamine secreting tumours in pregnancy: a review. Endocrine Practice 22:357–370.
  • Riester A, Reincke M. 2015. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy. European Journal of Endocrinology 172:R23–30.
  • Rigo J, Jr Glaz E, Papp Z. 1996. Low or high doses of spironolactone for treatment of maternal Bartter’s syndrome. American Journal of Obstetrics and Gynecology 174:297.
  • Sammour RN, Saiegh L, Matter I, Gonen R, Shechner C, Cohen M, et al. 2012. Adrenalectomy for adrenocortical adenoma causing Cushing's syndrome in pregnancy: a case report and review of literature. European Journal of Obstetrics & Gynecology and Reproductive Biology 165:1–7.
  • Sarathi V, Lila AR, Bandgar TR, Menon PS, Shah NS. 2010. Pheochromocytoma and pregnancy: a rare but dangerous combination. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 16:300–309.
  • Schenker JG, Granat M. 1982. Pheochromocytoma and pregnancy- an updated appraisal. The Australian and New Zealand Journal of Obstetrics and Gynaecology 22:1–10.
  • Schneiderman M, Czuzoj-Shulman N, Spence AR, Abenhaim HA. 2017. Maternal and neonatal outcomes of pregnancies in women with Addison's disease: a population-based cohort study on 7.7 million births. BJOG: An International Journal of Obstetrics & Gynaecology 124:1772–1779.
  • Sek KS, Deepak DS, Lee KO. 2017. Use of cabergoline for the management of persistent Cushing's disease in pregnancy. BMJ Case Report: bcr-2016-217855. doi:10.1136/bcr-2016-217855.
  • Tomaszewski C, Dewailly D. 2012. Hypercorticism and pheochromocytoma during pregnancy. In: Letombe B, Catteau-Jonard S, editors. Endocrinology in Gynecology and Obstetrics. Paris (France): Masson Elsevier; p. 233–240.
  • Touiti A, Mghari GE. 2015. Cushing syndrome during pregnancy: about a case of adrenal adenoma. Pan African Medical Journal 21:81.
  • Toutounchi S, Makowska A, Krajewska E, Fiszer P, Cieśla W, Pogorzelski R, et al. 2011. Laparoscopic treatment of Cushing’s syndrome in a woman in late pregnancy – a case presentation. Videosurgery and Other Miniinvasive Techniques 6:261–226.
  • van der Vaart CH, Heringa MP, Dullaart RP, Aarnoudse JG. 1993. Multiple endocrine neoplasia presenting as phaeochromocytoma during pregnancy. British Journal of Obstetrics and Gynaecology 100:1144–1145.
  • van der Weerd K, van Noord C, Loeve M, Knapen MFCM, Visser W, de Herder WW, et al. 2017. Endocrinology in pregnancy. Pheochromocytoma in pregnancy: case series and review of literature. European Journal of Endocrinology 177:R49–R58.
  • Verdonk K, Visser W, Van Den Meiracker AH, Danser AHJ. 2014. The renin-angiotensin aldosterone system in pre-eclampsia: the delicate balance between good and bad. Clinical Science (London, England: 1979) 126:537–544.
  • Versmissen J, Koch BCP, Roofthooft DWE, ten Bosch-Dijksman W, van den Meiracker AH, Hanff LM, et al. 2016. Doxazosin treatment of phaeochromocytoma during pregnancy: placental transfer and disposition in breast milk. British Journal of Clinical Pharmacology 82:568–569.
  • Woo I, Ehsanipoor RM. 2013. Cabergoline therapy for Cushing disease throughout pregnancy. Obstetrics and Gynecology 122:485–487.
  • Zieleniewski W, Michalak R. 2017. A successful case of pregnancy in a woman with ACTH-independent Cushing's syndrome treated with ketoconazole and metyrapone. Gynecology and Endocrinology 33:349–352. May

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.